Asia calls for urgency in typhoid vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2012
Singapore: The Coalition against Typhoid (CaT) called on policymakers and ministries of health across Asia to make typho...Read more
Novozyme, EpiVax to develop therapy for autoimmune diseases
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 23 Dec, 2014
Singapore: Novozymes Biopharma and vaccine firm, EpiVax, have entered into two years' areement for the development of no...Read more
Influenza creates havoc in northeast Thailand
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2014
Singapore: A seasonal flu is multiplying in large numbers in the lower northeast region of Thailand almost doubling this...Read more
Thai scientist 'raps' vaccine song, wins award
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2013
Singapore: Dr Phanramphoei Namprachan Frantz, a researcher at the virology and cell technology laboratory, National Cent...Read more
Sanofi dengue vaccine demonstrates proof of efficacy
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2012
Singapore: The tetravalent dengue vaccine candidate of Sanofi Pasteur, the vaccines division of Sanofi, demonstrated pro...Read more
Takeda's dengue vaccine trials to being in 2015
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2014
Singapore: Japan's pharma giant Takeda Pharmaceutical has said that it is planning to begin the last phase of clinical t...Read more
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 19 Sep, 2014
Singapore: In its mission to eradicate polio, Nepal had recently launched a polio eradication drive by supplementing ora...Read more
Urgent need arises for SARS vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 29 Nov, 2012
Singapore: The World Health Organization (WHO) reported four new cases of SARS-like virus in Saudi Arabia and Qatar, an...Read more
IAVI reafirms its commitment to AIDS vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 22 May, 2014
Singapore: "Do you remember the world before HIV/AIDS? Where will you be when the shadow of this disease is finally gone...Read more
CSL progresses on Novartis influenza vaccine biz acquisition
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2015
Singapore: Australia based drug development company, CSL, has secured the necessary approvals required to proceed with t...Read more
Hospira recalls propofol injectable due to visible particulates in vial
Vaccines | Regulatory | By BioSpectrum Bureau | 3 Comment | 21 Apr, 2014
Singapore: Hospira has issued a nationwide recall of seven lots of Propofol Injectable Emulsion to the user level due to...Read more
Experimental chikungunya vaccine induces antibody response
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 18 Aug, 2014
Singapore: An experimental vaccine to prevent the mosquito-borne viral illness chikungunya has elicited neutralizing ant...Read more
Medicago achieves milestone in VLP vaccine production
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2012
Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based o...Read more
J&J begins Ebola vaccine trial in humans
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2015
Singapore: The trial is being led by the Oxford Vaccine Group, part of the University of Oxford Department of Pediatrics...Read more
Influenza can get worse with every season
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2012
Singapore: Acute viral respiratory infection influenza, or flu, strikes every winter, and several nations are preparing ...Read more
Bill Gates commits $50 mn to combat Ebola
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2014
Singapore: Bill & Melinda Gates Foundation has commited USD50 million to support the scale up of emergency efforts t...Read more
Pfizer to acquire Baxter's vaccine portfolio at $635 mn
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2014
Singapore: Pfizer plans to acquire marketed vaccines portfolio of Baxter International at $635 million. As part of the ...Read more
Intra-nasal vaccine: Answer to avian influenza threat
Vaccines | Analysis | By BioSpectrum Bureau | 2 Comment | 18 Jul, 2012
There is a fear that avian H5N1 virus could cause a pandemic of new influenza in humans without any warning. To prevent ...Read more